Yellow fever cases in Asia: primed for an epidemic

International Journal of Infectious Diseases

Volumn 48, Issue , 2016, Pages 98-103

  Wasserman, Sean ^a   Tambyah, Paul Anantharajah ^b   Lim, Poh Lian ^c,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Aedes aegypti; Arboviruses; Emerging infectious diseases; Flaviviruses; Yellow fever

Indexed keywords

AFRICA; ASIA; CLINICAL FEATURE; DISEASE RE-EMERGENCE; ECOLOGY; EPIDEMIC; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; NONHUMAN; REVIEW; WESTERN HEMISPHERE; YELLOW FEVER; AEDES; ANIMAL; INSECT VECTOR; VIROLOGY;

AEDES; ANIMALS; ASIA; DISEASE OUTBREAKS; EPIDEMICS; HUMANS; INSECT VECTORS; YELLOW FEVER;

EID: 84969746088     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.04.025     Document Type: Review

References (63)

1. 1 ProMED. Yellow fever—Africa (02): Angola (Luanda) request for information: International Society for Infectious Diseases. ProMED-mail; 2016. Available at: http://www.promedmail.org/post/3958601 (accessed April 11, 2016).
2. 2 ProMED. Yellow fever—Africa (05): Angola (Huila): International Society for Infectious Diseases. ProMED-mail; 2016. Available at: http://www.promedmail.org/post/3977685 (accessed April 11, 2016).
3. 3 World Health Organization. Yellow fever—Democratic Republic of the Congo, 11 April 2016. Geneva: WHO; 2016. Available at: http://www.who.int/csr/don/11-april-2016-yellow-fever-drc/en/ (accessed April 20, 2016).
4. 4 World Health Organization. Yellow Fever—Kenya, 6 April 2016. Geneva: WHO; 2016. Available at: http://www.who.int/csr/don/6-april-2016-yellow-fever-kenya/en/ (accessed April 20, 2016).
5. 5 Lai, S., Huang, Z., Zhou, H., Anders, K.L., Perkins, T.A., Yin, W., et al. The changing epidemiology of dengue in China, 1990–2014: a descriptive analysis of 25 years of nationwide surveillance data. BMC Med, 13, 2015, 100, 10.1186/s12916-015-0336-1.
6. 6 Monath, T.P., Yellow fever: an update. Lancet Infect Dis 1 (2001), 11–20, 10.1016/s1473-3099(01)00016-0.
7. 7 World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. 2009, World Health Organization, Geneva.
8. 8 Carrington, C.V., Auguste, A.J., Evolutionary and ecological factors underlying the tempo and distribution of yellow fever virus activity. Infect Genet Evol 13 (2013), 198–210, 10.1016/j.meegid.2012.08.015.
9. 9 Cathey, J.T., Marr, J.S., Yellow fever, Asia and the East African slave trade. Trans R Soc Trop Med Hyg 108 (2014), 252–257, 10.1093/trstmh/tru043.
10. 10 Bryant, J.E., Holmes, E.C., Barrett, A.D., Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog, 3, 2007, e75, 10.1371/journal.ppat.0030075.
11. 11 Tabachnick, W.J., Evolutionary genetics and arthropod-borne disease: the yellow fever mosquito. American Entomologist 37 (1991), 14–26.
12. 12 Rogers, D.J., Wilson, A.J., Hay, S.I., Graham, A.J., The global distribution of yellow fever and dengue. Adv Parasitol 62 (2006), 181–220, 10.1016/s0065-308x(05)62006-4.
13. 13 Reiter, P., Yellow fever and dengue: a threat to Europe. Euro Surveill, 15, 2010, 19509.
14. 14 Gubler, D.J., The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?. Comp Immunol Microbiol Infect Dis 27 (2004), 319–330, 10.1016/j.cimid.2004.03.013.
15. 15 Soper, F.L., The elimination of urban yellow fever in the Americas through the eradication of Aedes aegypti. Am J Public Health Nations Health 53 (1963), 7–16.
16. 16 Gubler, D.J., Resurgent vector-borne diseases as a global health problem. Emerg Infect Dis 4 (1998), 442–450, 10.3201/eid0403.980326.
17. 17 Robertson, S.E., Hull, B.P., Tomori, O., Bele, O., LeDuc, J.W., Esteves, K., Yellow fever: a decade of reemergence. JAMA 276 (1996), 1157–1162.
18. 18 Pan American Health Organization. Technical Report: Recommendations for scientific evidence-based yellow fever risk assessment in the Americas. PAHO; 2013. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&Itemid=270&gid=30613&lang=en (accessed April 11, 2016).
19. 19 Monath, T.P., Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg 45 (1991), 1–43.
20. 20 Nasidi, A., Monath, T.P., Vandenberg, J., Tomori, O., Calisher, C.H., Hurtgen, X., et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 87 (1993), 337–339.
21. 21 Garske, T., Van Kerkhove, M.D., Yactayo, S., Ronveaux, O., Lewis, R.F., Staples, J.E., et al. Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med, 11, 2014, e1001638, 10.1371/journal.pmed.1001638.
22. 22 Monath, T.P., Yellow fever as an endemic/epidemic disease and priorities for vaccination. Bull Soc Pathol Exot 99 (2006), 341–347.
23. 23 World Health Organization. Global and regional immunization profile: African region. Geneva: WHO; 2015. Available at: http://www.who.int/immunization/monitoring_surveillance/data/gs_afrprofile.pdf?ua=1 (accessed April 12, 2016).
24. 24 Massad, E., Coutinho, F.A., Burattini, M.N., Lopez, L.F., The risk of yellow fever in a dengue-infested area. Trans R Soc Trop Med Hyg 95 (2001), 370–374.
25. 25 Monath, T.P., Facing up to re-emergence of urban yellow fever. Lancet, 353, 1999, 1541, 10.1016/s0140-6736(99)00155-5.
26. 26 Barrett, A.D., Higgs, S., Yellow fever: a disease that has yet to be conquered. Ann Rev Entomol 52 (2007), 209–229, 10.1146/annurev.ento.52.110405.091454.
27. 27 Van der Stuyft, P., Gianella, A., Pirard, M., Cespedes, J., Lora, J., Peredo, C., et al. Urbanisation of yellow fever in Santa Cruz. Bolivia. Lancet 353 (1999), 1558–1562.
28. 28 World Health Organization. Outbreak news. Yellow fever, Paraguay. Wkly Epidemiol Rec, 83, 2008, 105.
29. 29 Johansson, M.A., Arana-Vizcarrondo, N., Biggerstaff, B.J., Gallagher, N., Marano, N., Staples, J.E., Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008. Am J Trop Med Hyg 86 (2012), 349–358, 10.4269/ajtmh.2012.11-0432.
30. 30 Sanders, E.J., Marfin, A.A., Tukei, P.M., Kuria, G., Ademba, G., Agata, N.N., et al. First recorded outbreak of yellow fever in Kenya, 1992–1993. I. Epidemiologic investigations. Am J Trop Med Hyg 59 (1998), 644–649.
31. 31 Tomori, O., Yellow fever: the recurring plague. Crit Rev Clin Lab Sci 41 (2004), 391–427, 10.1080/10408360490497474.
32. 32 Mutebi, J.P., Barrett, A.D., The epidemiology of yellow fever in Africa. Microbes Infect 4 (2002), 1459–1468.
33. 33 Powell, J.R., Tabachnick, W.J., History of domestication and spread of Aedes aegypti—a review. Mem Inst Oswaldo Cruz 108 Suppl 1 (2013), 11–17, 10.1590/0074-0276130395.
34. 34 Beaty, B., Aitken, T., In vitro transmission of yellow fever virus by geographic strains of Aedes aegypti. Mosquito News 39 (1979), 232–238.
35. 35 Mahaffy, A., Hughes, T., Smithburn, K., Kirk, R., The isolation of yellow fever virus in the Anglo-Egyptian Sudan. Ann Trop Med Parasit 35 (1941), 141–148.
36. 36 Serie, C., Andral, L., Poirier, A., Lindrec, A., Neri, P., [Studies on yellow fever in Ethiopia. 6. Epidemiologic study]. Bull World Health Organ 38 (1968), 879–884.
37. 37 Gubler, D.J., The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33 (2002), 330–342.
38. 38 Abrão, E., Fonseca, B., Yellow fever virus interferes with dengue-2 replication and might prevent reurbanization of yellow fever. XVII National Meeting of Virology, Campos do Jordão, SP. Virus Rev Res 2006 (2006), 130–131.
39. 39 Abrão E, Fonseca B. Viral interference among flaviviruses: the case of dengue-2 and yellow fever viruses. 26th Annual Meeting of The American Society for Virology; 2007, p. 273.
40. 40 Theiler, M., Anderson, C.R., The relative resistance of dengue-immune monkeys to yellow fever virus. Am J Trop Med Hyg 24 (1975), 115–117.
41. 41 Xiao, S.Y., Guzman, H., da Rosa, A.P., Zhu, H.B., Tesh, R.B., Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses. Am J Trop Med Hyg 68 (2003), 695–703.
42. 42 Amaku, M., Coutinho, F.A., Massad, E., Why dengue and yellow fever coexist in some areas of the world and not in others?. Bio Systems 106 (2011), 111–120, 10.1016/j.biosystems.2011.07.004.
43. 43 Mutebi, J.P., Wang, H., Li, L., Bryant, J.E., Barrett, A.D., Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J Virol 75 (2001), 6999–7008, 10.1128/jvi.75.15.6999-7008.2001.
44. 44 Black, W.C., Bennett, K.E., Gorrochotegui-Escalante, N., Barillas-Mury, C.V., Fernandez-Salas, I., de Lourdes Munoz, M., et al. Flavivirus susceptibility in Aedes aegypti. Arch Med Res 33 (2002), 379–388.
45. 45 Burt, F.J., Rolph, M.S., Rulli, N.E., Mahalingam, S., Heise, M.T., Chikungunya: a re-emerging virus. Lancet 379 (2012), 662–671, 10.1016/s0140-6736(11)60281-x.
46. 46 Arankalle, V.A., Shrivastava, S., Cherian, S., Gunjikar, R.S., Walimbe, A.M., Jadhav, S.M., et al. Genetic divergence of chikungunya viruses in India (1963–2006) with special reference to the 2005–2006 explosive epidemic. J Gen Virol 88:Pt 7 (2007), 1967–1976, 10.1099/vir.0.82714-0.
47. 47 Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika virus. N Engl J Med 374 (2016), 1552–1563, 10.1056/NEJMra1602113.
48. 48 Petersen, E., Wilson, M.E., Touch, S., McCloskey, B., Mwaba, P., Bates, M., et al. Rapid spread of Zika virus in the Americas—implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games. Int J Infect Dis 44 (2016), 11–15, 10.1016/j.ijid.2016.02.001.
49. 49 IATA press release: Airlines to welcome 3.6 billion passengers in 2016. IATA; 2012. Available at: http://www.iata.org/pressroom/pr/pages/2012-12-06-01.aspx (accessed April 15, 2016).
50. 50 Miller, B.R., Monath, T.P., Tabachnick, W.J., Ezike, V.I., Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol 40 (1989), 396–399.
51. 51 Monath, T.P., Cetron, M.S., Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34 (2002), 1369–1378, 10.1086/340104.
52. 52 Kraemer, M.U., Sinka, M.E., Duda, K.A., Mylne, A.Q., Shearer, F.M., Barker, C.M., et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. eLife, 4, 2015, e08347, 10.7554/eLife.08347.
53. 53 Jentes, E.S., Poumerol, G., Gershman, M.D., Hill, D.R., Lemarchand, J., Lewis, R.F., et al. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Gr oup on Geographic Risk for Yellow Fever. Lancet Infect Dis 11 (2011), 622–632, 10.1016/s1473-3099(11)70147-5.
54. 54 HealthMap. Available at: http://www.healthmap.org/promed/ (accessed April 27, 2016).
55. 55 FLIRT. Available at: http://flirt.eha.io/ (accessed April 27, 2016).
56. 56 World Health Organization. Risk assessment on yellow fever virus circulation in endemic countries: working document from an informal consultation of experts: a protocol risk assessment at the field level. 2014, WHO, Geneva.
57. 57 Bres, P.L., A century of progress in combating yellow fever. Bull World Health Organ 64 (1986), 775–786.
58. 58 Tomori, O., Yellow fever in Africa: public health impact and prospects for control in the 21st century. Biomedica 22 (2002), 178–210.
59. 59 Morrison, A.C., Zielinski-Gutierrez, E., Scott, T.W., Rosenberg, R., Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Med, 5, 2008, e68, 10.1371/journal.pmed.0050068.
60. 60 World Health Organization. International Health Regulations 2005. 2008, WHO, Geneva.
61. 61 Martins, R.M., Maia Mde, L., Farias, R.H., Camacho, L.A., Freire, M.S., Galler, R., et al. 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum Vaccin Immunother 9 (2013), 879–888, 10.4161/hv.22982.
62. 62 Monath, T.P., Woodall, J.P., Gubler, D.J., Yuill, T.M., Mackenzie, J.S., Martins, R.M., et al. Yellow fever vaccine supply: a possible solution. Lancet 387 (2016), 1599–1600, 10.1016/S0140-6736(16)30195-7.
63. 63 Lim, P.L., Schistosoma haematobium in China, ex-Africa: new populations at risk?. J Travel Med 20 (2013), 211–213, 10.1111/jtm.12031.